1-4 of 4
Melissa L. Teichman, PharmD
Close
Sort by
Journal Articles

Rapid Infusion Rituximab in Maintenance Therapy: Is It Feasible?

Jolly R Patel, PharmD, Viet Q. Ho, PharmD, BCOP, Melissa L. Teichman, PharmD, BCOP, Lubomir Sokol, MD, PhD, Celeste M. Bello, MD, Jennifer L. Cultrera, MD, Eduardo M. Sotomayor, Gene A. Wetzstein, PharmD, BCOP
Journal: Blood
Blood (2011) 118 (21): 4973.
https://doi.org/10.1182/blood.V118.21.4973.4973
Published: 2011
Journal Articles

Prognostic Factors of Response and Survival in CMML Patients Treated with Azacitidine (AZA)

Lionel Ades, Mikkael A. Sekeres, MD, MS, Alice Wolfromm, Melissa L. Teichman, PharmD, BCOP, Ramon V. Tiu, MD, Raphael Itzykson, MD, Jaroslaw P. Maciejewski, MD, PhD, Francois Dreyfus, Alan F. List, MD, Pierre Fenaux, Rami S. Komrokji, MD
Journal: Blood
Blood (2011) 118 (21): 1726.
https://doi.org/10.1182/blood.V118.21.1726.1726
Published: 2011
Journal Articles

Efficacy of Ofatumumab and High-Dose Methylprednisolone for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Melissa L. Teichman, PharmD, BCOP, Viet Q. Ho, PharmD, BCOP, Lodovico Balducci, MD, Celeste M. Bello, MD, Javier Pinilla-Ibarz, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 4619.
https://doi.org/10.1182/blood.V118.21.4619.4619
Published: 2011
Journal Articles

Efficacy of Azacitidine In the Treatment of Chronic Myelomonocytic Leukemia

Melissa L. Teichman, PharmD, Gene A. Wetzstein, PharmD, BCOP, Viet Q. Ho, PharmD, BCOP, Jeffrey E. Lancet, MD, Alan F. List, Rami S. Komrokji, MD
Journal: Blood
Blood (2010) 116 (21): 4017.
https://doi.org/10.1182/blood.V116.21.4017.4017
Published: 2010